Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Peripheral Arterial Disease in Women: an Overview of Risk Factor Profile, Clinical Features, and Outcomes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management

    Research output: Contribution to journalReviewResearchpeer-review

  2. Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy

    Research output: Contribution to journalReviewResearchpeer-review

  3. Antisense Oligonucleotides Targeting Lipoprotein(a)

    Research output: Contribution to journalReviewResearchpeer-review

  4. Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Qurat-Ul-Ain Jelani
  • Mikhail Petrov
  • Sara C Martinez
  • Lene Holmvang
  • Khaled Al-Shaibi
  • Mirvat Alasnag
View graph of relations

PURPOSE OF REVIEW: Peripheral arterial disease (PAD) is the third most common manifestation of cardiovascular disease (CVD), following coronary artery disease (CAD) and stroke. PAD remains underdiagnosed and under-treated in women.

RECENT FINDINGS: Women with PAD experience more atypical symptoms and poorer overall health status. The prevalence of PAD in women increases with age, such that more women than men have PAD after the age of 40 years. There is under-representation of PAD patients in clinical trials in general and women in particular. In this article, we address the lack of women participants in PAD trials. We then present a comprehensive overview of the epidemiology/risk factor profile, clinical features, treatment, and outcomes. PAD is prevalent in women and its global burden is on the rise despite a decline in global age-standardized death rate from CVD. The importance of this issue has been underlined by the American Heart Association's (AHA) "Call to Action" scientific statement on PAD in women. Large-scale campaigns are needed to increase awareness among physicians and the general public. Furthermore, effective treatment strategies must be implemented.

Original languageEnglish
JournalCurrent Atherosclerosis Reports
Volume20
Issue number8
Pages (from-to)40
ISSN1523-3804
DOIs
Publication statusPublished - 2 Jun 2018

ID: 56430644